Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
A personalized cancer vaccine plus Keytuda lowered the risk of melanoma coming back after surgery.
Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.
Randall N. Hyer, MD, PhD, will continue Blumberg Institute’s hepatitis B and liver cancer research in his new role as president.
NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.
An NIH-sponsored study assessed boosters for adults fully vaccinated with any authorized or approved COVID-19 vaccine.
People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.
Many people who received any of the authorized COVID-19 vaccines are now eligible for an additional dose of their choice.
People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.
Third booster dose may improve immune response in cancer patients without sufficient protection after second dose.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.
A slow vaccine rollout and the emergence of new coronavirus mutations threaten progress in reducing new cases and death.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.